000919 金陵药业
已收盘 04-03 15:00:00
资讯
新帖
简况
金陵药业:截至2026年3月31日,公司股东人数为33,297
证券之星 · 04-02 11:33
金陵药业:截至2026年3月31日,公司股东人数为33,297
图解金陵药业年报:第四季度单季净利润同比增长59.99%
证券之星 · 03-31
图解金陵药业年报:第四季度单季净利润同比增长59.99%
股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元
证券之星 · 03-24
股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元
金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%
证券之星 · 03-12
金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%
金陵药业:截至2026年2月27日,公司股东人数为34,125
证券之星 · 03-03
金陵药业:截至2026年2月27日,公司股东人数为34,125
股市必读:金陵药业(000919)2月25日董秘有最新回复
证券之星 · 02-26
股市必读:金陵药业(000919)2月25日董秘有最新回复
金陵石化与京东政企业务签署合作协议
中国石化报 · 02-25
金陵石化与京东政企业务签署合作协议
金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%
证券之星 · 02-24
金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%
金陵药业(000919.SZ)子公司补缴税款841.15万元
智通财经网 · 02-12
金陵药业(000919.SZ)子公司补缴税款841.15万元
金陵药业:截至2026年2月10日,公司股东人数为34,654
证券之星 · 02-12
金陵药业:截至2026年2月10日,公司股东人数为34,654
金陵药业(000919)披露2026年度日常关联交易预计议案获临时股东大会通过,2月5日股价上涨0.77%
证券之星 · 02-05
金陵药业(000919)披露2026年度日常关联交易预计议案获临时股东大会通过,2月5日股价上涨0.77%
金陵药业(000919)1月30日股东户数3.35万户,较上期减少1.98%
证券之星 · 02-03
金陵药业(000919)1月30日股东户数3.35万户,较上期减少1.98%
金陵药业:截至2026年1月30日,公司股东人数为33,513
证券之星 · 02-02
金陵药业:截至2026年1月30日,公司股东人数为33,513
金陵药业(000919)披露使用闲置募集资金进行现金管理的进展公告,1月29日股价上涨0.13%
证券之星 · 01-29
金陵药业(000919)披露使用闲置募集资金进行现金管理的进展公告,1月29日股价上涨0.13%
股市必读:金陵药业(000919)股东户数3.42万户,较上期减少4.54%
证券之星 · 01-23
股市必读:金陵药业(000919)股东户数3.42万户,较上期减少4.54%
业绩连降、核心项目延期,金陵药业如何走出业绩低谷?
新京报 · 01-22
业绩连降、核心项目延期,金陵药业如何走出业绩低谷?
金陵药业(000919)披露召开2026年第一次临时股东会通知,1月21日股价上涨1.14%
证券之星 · 01-21
金陵药业(000919)披露召开2026年第一次临时股东会通知,1月21日股价上涨1.14%
金陵药业:截至2026年1月9日股东人数为35,817
证券之星 · 01-13
金陵药业:截至2026年1月9日股东人数为35,817
金陵药业:截至2025年12月31日股东人数为36,305
证券之星 · 01-06
金陵药业:截至2025年12月31日股东人数为36,305
金陵药业子公司使用闲置募集资金进行现金管理进展公告
中金财经 · 2025-12-30
金陵药业子公司使用闲置募集资金进行现金管理进展公告
加载更多
公司概况
公司名称:
金陵药业股份有限公司
所属行业:
医药制造业
上市日期:
1999-11-18
主营业务:
金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。
发行价格:
8.40
{"stockData":{"symbol":"000919","market":"SZ","secType":"STK","nameCN":"金陵药业","latestPrice":7.36,"timestamp":1775199807000,"preClose":7.42,"halted":0,"volume":13212947,"delay":0,"changeRate":-0.0081,"floatShares":622000000,"shares":622000000,"eps":0.1085,"marketStatus":"已收盘","change":-0.06,"latestTime":"04-03 15:00:00","open":7.4,"high":7.52,"low":7.26,"amount":97290900,"amplitude":0.035,"askPrice":7.36,"askSize":512,"bidPrice":7.35,"bidSize":61,"shortable":0,"etf":0,"ttmEps":0.1085,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775525400000},"marketStatusCode":5,"adr":0,"adjPreClose":7.42,"symbolType":"stock","openAndCloseTimeList":[[1775179800000,1775187000000],[1775192400000,1775199600000]],"highLimit":8.16,"lowLimit":6.68,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":621924528,"isCdr":false,"pbRate":1.22,"roa":"--","peRate":67.834101,"roe":"1.42%","epsLYR":0.0867,"committee":-0.359831,"marketValue":4577000000,"turnoverRate":0.0213,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-04-08。","floatMarketCap":4576000000},"requestUrl":"/m/hq/s/000919","defaultTab":"news","newsList":[{"id":"2624617524","title":"金陵药业:截至2026年3月31日,公司股东人数为33,297","url":"https://stock-news.laohu8.com/highlight/detail?id=2624617524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624617524?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:33","pubTimestamp":1775100797,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至3月31日公司的股东是多少?谢谢金陵药业回复:投资者,您好!截至2026年3月31日,公司股东人数为33,297,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200014925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623323557","title":"图解金陵药业年报:第四季度单季净利润同比增长59.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623323557","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623323557?lang=zh_cn&edition=full","pubTime":"2026-03-31 02:06","pubTimestamp":1774894012,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业2025年年报显示,当年度公司主营收入31.97亿元,同比下降2.56%;归母净利润5391.46万元,同比上升33.42%;扣非净利润3500.49万元,同比下降28.45%;其中2025年第四季度,公司单季度主营收入8.17亿元,同比上升8.83%;单季度归母净利润-1454.37万元,同比上升59.99%;单季度扣非净利润-2163.93万元,同比下降761.05%;负债率19.72%,投资收益3019.59万元,财务费用-1206.16万元,毛利率20.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100004962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621408298","title":"股市必读:金陵药业(000919)3月23日收盘跌7.18%,主力净流入81.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621408298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621408298?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:47","pubTimestamp":1774298831,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,金陵药业报收于6.59元,下跌7.18%,换手率2.39%,成交量14.87万手,成交额1.0亿元。交易信息汇总3月23日金陵药业收盘报6.59元,跌7.18%,当日成交1487.25万元。根据收盘数据统计,该股已连续3日下跌。前10个交易日资金流向情况:主力资金累计净流出3440.41万元,股价累计下跌9.52%。资金流向3月23日主力资金净流入81.77万元;游资资金净流入1473.07万元;散户资金净流出1554.84万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618831187","title":"金陵药业(000919)3月10日股东户数3.34万户,较上期减少2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618831187","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618831187?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:11","pubTimestamp":1773306674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年3月10日公司股东户数为3.34万户,较2月27日减少695.0户,减幅为2.04%。在化学制药行业个股中,金陵药业股东户数低于行业平均水平,截至3月10日,化学制药行业平均股东户数为3.42万户。从股价来看,2026年2月27日至2026年3月10日,金陵药业区间跌幅为1.59%,在此期间股东户数减少695.0户,减幅为2.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200027804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616316036","title":"金陵药业:截至2026年2月27日,公司股东人数为34,125","url":"https://stock-news.laohu8.com/highlight/detail?id=2616316036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616316036?lang=zh_cn&edition=full","pubTime":"2026-03-03 15:16","pubTimestamp":1772522185,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)03月03日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2月底 公司股东人数有多少?谢谢金陵药业回复:投资者,您好!截至2026年2月27日,公司股东人数为34,125,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300021085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","000919","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614032225","title":"股市必读:金陵药业(000919)2月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614032225","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614032225?lang=zh_cn&edition=full","pubTime":"2026-02-26 01:29","pubTimestamp":1772040551,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,金陵药业报收于7.67元,上涨1.19%,换手率2.39%,成交量14.86万手,成交额1.15亿元。截至2026年2月13日,公司股东人数为34,034,感谢您对公司的关注。公司公告汇总金陵药业股份有限公司关于全资子公司清算注销完成的公告金陵药业股份有限公司于2025年11月26日召开董事会,审议通过清算注销全资子公司湖州邦健天峰药业有限公司的议案。邦健天峰将不再纳入公司合并报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600000813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614727514","title":"金陵石化与京东政企业务签署合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2614727514","media":"中国石化报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614727514?lang=zh_cn&edition=full","pubTime":"2026-02-25 08:47","pubTimestamp":1771980431,"startTime":"0","endTime":"0","summary":"本报讯 近日,金陵石化与京东政企业务在北京签署合作协议。金陵石化在能源供应与化工产品领域具有显著优势。京东政企业务则凭借京东集团稳定、高效的供应链基础设施,为政企客户提供一站式、全链路、场景化的数智采购供应链综合解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225084717a71baf07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225084717a71baf07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1328277881.USD","SG9999002828.SGD","LU1282649810.SGD","LU0431992006.USD","LU0228367735.SGD","LU2257852520.SGD","LU0259732245.USD","LU1282651121.HKD","LU1770034418.SGD","LU0488056044.USD","LU0228659784.USD","LU0417516738.SGD","LU0320764755.SGD","LU0315178854.USD","LU0588545904.SGD","LU1044875133.USD","LU1481107354.HKD","LU0348735423.USD","LU0384037296.USD","LU0048580855.USD","LU0791591158.USD","LU0320764599.SGD","LU1224444064.USD","LU1770036033.HKD","LU0051755006.USD","000919","LU0164865239.USD","LU1642822792.SGD","LU2039709279.SGD","LU0084288322.USD","LU1044876610.USD","LU0588545730.USD","LU1282649067.USD","LU0499858438.USD","LU1808992512.USD","BK1249","LU0211977185.USD","LU0417516902.SGD","LU0348825331.USD","LU0163747925.USD","LU0499858602.USD","LU0164880469.USD","BK1591","SG9999002562.SGD","LU1720050803.USD","LU0543330483.HKD","LU0650527681.SGD","LU1366334578.USD","BK1142","LU0359201885.HKD","LU1044874839.SGD","LU0149721374.USD","LU0791590937.USD","LU0359201612.USD","LU0572944931.SGD","LU0140636845.USD","LU0865486749.SGD","LU0327786744.USD","LU0345776255.USD","LU0231483743.USD","LU1719994722.HKD","LU0348805143.USD","LU1794554557.SGD","LU0456842615.SGD","LU0029875118.USD","LU0039217434.USD","LU1303224171.USD","BK1619","LU1023057109.AUD","BK1502","JD","LU0293314216.USD","BK1575","LU0868486357.SGD","LU0307460666.USD","LU0588545490.SGD","LU0828237510.HKD","LU1813983027.USD","SG9999001226.SGD","IE00B29SXG58.USD","LU2242644610.SGD","LU0708995583.HKD","IE00BGV7N243.SGD","BK1610","LU1366334651.USD","89618","LU0672654166.SGD","LU1251922891.USD","LU0588546209.SGD","09618","LU0052750758.USD","BK1588","LU0128522157.USD","LU0469268626.HKD","LU0456846285.SGD","LU0314109678.HKD","LU1282651048.USD","BK1615","LU0871576103.HKD","IE0032431581.USD","LU0370786039.SGD","LU0594300419.USD","LU0345775950.USD","LU0359202008.SGD","LU0456827905.SGD","LU0531971595.HKD","IE00B3M56506.USD","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613790703","title":"金陵药业(000919)披露全资子公司清算注销完成公告,2月24日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613790703","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613790703?lang=zh_cn&edition=full","pubTime":"2026-02-24 19:03","pubTimestamp":1771931037,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘,金陵药业报收于7.58元,较前一交易日上涨1.88%,最新总市值为47.14亿元。金陵药业股份有限公司近日发布《关于全资子公司清算注销完成的公告》。公告显示,公司于2025年11月26日召开董事会,审议通过清算注销全资子公司湖州邦健天峰药业有限公司的议案。近日,公司收到湖州市市场监督管理局湖州南太湖区分局出具的《登记通知书》,邦健天峰清算注销手续已办理完毕。邦健天峰将不再纳入公司合并报表范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610945280","title":"金陵药业(000919.SZ)子公司补缴税款841.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945280","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610945280?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:07","pubTimestamp":1770887268,"startTime":"0","endTime":"0","summary":"智通财经APP讯,金陵药业(000919.SZ)发布公告,公司控股子公司南京鼓楼医院集团宿迁医院有限公司(以下简称“宿迁医院”)近日收到国家税务总局宿迁市税务局稽查局的税务处理决定书,根据税务机关的要求,宿迁医院需补缴2022年至2024年期间的税款及滞纳金841.15万元。截止本公告日,上述税款及滞纳金已经全部缴纳,本次不涉及行政处罚。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404692.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","000919","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610180917","title":"金陵药业:截至2026年2月10日,公司股东人数为34,654","url":"https://stock-news.laohu8.com/highlight/detail?id=2610180917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610180917?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:42","pubTimestamp":1770882133,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至2月10日公司的股东人数是多少?谢谢金陵药业回复:投资者,您好!截至2026年2月10日,公司股东人数为34,654,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200020128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","000919","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609011403","title":"金陵药业(000919)披露2026年度日常关联交易预计议案获临时股东大会通过,2月5日股价上涨0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609011403","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609011403?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:48","pubTimestamp":1770302899,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘,金陵药业报收于7.83元,较前一交易日上涨0.77%,最新总市值为48.7亿元。近日,金陵药业股份有限公司发布《2026年第一次临时股东会决议公告》。公告显示,公司于2026年2月5日召开2026年第一次临时股东会,会议采用现场与网络投票结合方式,审议通过了《关于公司2026年度日常关联交易预计情况的议案》。出席会议股东共205人,代表股份37,147,263股,占公司有表决权股份总数的5.9730%。议案获得同意票34,922,902股,反对2,059,361股,弃权165,000股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0096","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608821574","title":"金陵药业(000919)1月30日股东户数3.35万户,较上期减少1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608821574","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608821574?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:37","pubTimestamp":1770111458,"startTime":"0","endTime":"0","summary":"证券之星消息,近日金陵药业披露,截至2026年1月30日公司股东户数为3.35万户,较1月20日减少677.0户,减幅为1.98%。在化学制药行业个股中,金陵药业股东户数低于行业平均水平,截至1月30日,化学制药行业平均股东户数为3.43万户。从股价来看,2026年1月20日至2026年1月30日,金陵药业区间跌幅为3.43%,在此期间股东户数减少677.0户,减幅为1.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300030100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608773858","title":"金陵药业:截至2026年1月30日,公司股东人数为33,513","url":"https://stock-news.laohu8.com/highlight/detail?id=2608773858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608773858?lang=zh_cn&edition=full","pubTime":"2026-02-02 15:04","pubTimestamp":1770015865,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司截至1月30日的股东人数是多少?金陵药业回复:投资者,您好!截至2026年1月30日,公司股东人数为33,513,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200015109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607360430","title":"金陵药业(000919)披露使用闲置募集资金进行现金管理的进展公告,1月29日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607360430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607360430?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:06","pubTimestamp":1769699180,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘,金陵药业报收于7.61元,较前一交易日上涨0.13%,最新总市值为47.33亿元。公告显示,池州东升药业有限公司和合肥金陵天颐智慧养老服务有限公司此前购买的多笔大额存单产品已于2026年1月28日到期赎回,合计赎回本金并获得相应收益。同时,相关募集资金现金管理专用结算账户已由银行自动注销。截至公告日,公司使用闲置募集资金进行现金管理尚未到期的金额为49,600万元,未超出股东大会批准的额度范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","BK0028","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605411633","title":"股市必读:金陵药业(000919)股东户数3.42万户,较上期减少4.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605411633?lang=zh_cn&edition=full","pubTime":"2026-01-23 02:47","pubTimestamp":1769107630,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘,金陵药业报收于7.97元,上涨0.0%,换手率1.88%,成交量11.71万手,成交额9295.47万元。来自股本股东变化:截至2026年1月20日,公司股东户数环比减少4.54%,户均持股量上升至1.82万股,表明筹码集中度有所提升。股本股东变化股东户数变动近日金陵药业披露,截至2026年1月20日公司股东户数为3.42万户,较1月9日减少1627.0户,减幅为4.54%。截至2026年1月20日,公司股东人数为34,190,感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300001485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0239","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605666224","title":"业绩连降、核心项目延期,金陵药业如何走出业绩低谷?","url":"https://stock-news.laohu8.com/highlight/detail?id=2605666224","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605666224?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:27","pubTimestamp":1769070420,"startTime":"0","endTime":"0","summary":"在业绩持续承压、转型布局遇阻的双重考验下,金陵药业该如何走出业绩低谷?募投滞后、资金闲置此次延期的核心原料药项目,是金陵药业2024年定增募资的重点投向之一。截至2025年9月底,金陵药业募集资金余额达7.29亿元,其中6.8亿元用于现金管理,闲置比例超过93%。不过,近年来,金陵药业核心业务增长乏力,业绩持续下滑。为扭转颓势,金陵药业已在积极寻求突围路径。2025年上半年,金陵药业研发投入4534.16万元,同比增长20.51%。","market":"hk","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl882026122162192878601.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2026/1/wangl882026122162192878601.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1769070421168010.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1769070421168010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["000919","BK0096","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605170685","title":"金陵药业(000919)披露召开2026年第一次临时股东会通知,1月21日股价上涨1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605170685","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605170685?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:37","pubTimestamp":1768988220,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘,金陵药业报收于7.97元,较前一交易日上涨1.14%,最新总市值为49.57亿元。该股当日开盘7.82元,最高8.1元,最低7.73元,成交额达1.42亿元,换手率为2.87%。公司近日发布公告称,将于2026年2月5日召开2026年第一次临时股东会,会议由董事会召集,现场会议时间为当日14:30,网络投票时间为同日9:15至15:00。股权登记日为2026年1月30日。股东可选择现场或网络投票方式参会,中小股东表决情况将单独计票。登记时间截至2026年2月4日17:00。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100029322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000919","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603571843","title":"金陵药业:截至2026年1月9日股东人数为35,817","url":"https://stock-news.laohu8.com/highlight/detail?id=2603571843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603571843?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:35","pubTimestamp":1768275303,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至1月10日公司的股东人数是多少?谢谢金陵药业回复:投资者,您好!截至2026年1月9日,公司股东人数为35,817,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300016060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000919","BK0096","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601986123","title":"金陵药业:截至2025年12月31日股东人数为36,305","url":"https://stock-news.laohu8.com/highlight/detail?id=2601986123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601986123?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:21","pubTimestamp":1767684076,"startTime":"0","endTime":"0","summary":"证券之星消息,金陵药业(000919)01月06日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,请问截止到2025年12月31日,贵公司股东户数是多少?谢谢啦!!!金陵药业回复:投资者,您好!截至2025年12月31日,公司股东人数为36,305,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600020059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0096","000919"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595308715","title":"金陵药业子公司使用闲置募集资金进行现金管理进展公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2595308715","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595308715?lang=zh_cn&edition=full","pubTime":"2025-12-30 23:18","pubTimestamp":1767107899,"startTime":"0","endTime":"0","summary":"根据公告,子公司合肥金陵天颐智慧养老服务有限公司此前购买的南京银行结构性存款产品已按期赎回,共计收回本金15,600万元及收益270.97万元。同时,该公司使用闲置募集资金新购买了南京银行的两款保本浮动收益型结构性存款产品,金额分别为11,000万元和4,600万元,期限均为360天。截至公告日,公司及子公司使用闲置募集资金进行现金管理尚未到期的余额为68,000万元,未超出股东大会批准的70,000万元额度范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251230/31905042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0096","BK0239","000919","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775243724016,"stockEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":0.0308},{"period":"3month","weight":-0.0742},{"period":"6month","weight":0.0745},{"period":"1year","weight":0.0917},{"period":"ytd","weight":-0.0742}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金陵药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33297人(较上一季度增加1.27%)","perCapita":"18673股","listingDate":"1999-11-18","address":"江苏省南京市栖霞区经济技术开发区新港大道58号","registeredCapital":"62192万元","survey":" 金陵药业股份有限公司的主营业务是药品、医疗器械制造和销售,以及医康养护服务。公司的主要产品是脉络宁注射液、脉络宁口服液、琥珀酸亚铁片、琥珀酸亚铁缓释片、香菇多糖注射液、吸收性明胶海绵、医疗服务、康养护服务。公司一直致力于打造自身的品牌优势和较高的知名度,“桂冠”商标为中国驰名商标,“脉络宁注射液”“琥珀酸亚铁片”被列入《国家基本药物目录》和《国家医保目录》。脉络宁注射液荣获2021年度中华民族医药优秀品牌企业代表产品。“速力菲”系列产品荣获“2021江苏省医药行业优秀产品品牌”。","listedPrice":8.4},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金陵药业,000919,金陵药业股票,金陵药业股票老虎,金陵药业股票老虎国际,金陵药业行情,金陵药业股票行情,金陵药业股价,金陵药业股市,金陵药业股票价格,金陵药业股票交易,金陵药业股票购买,金陵药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金陵药业(000919)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金陵药业(000919)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}